Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,585,982,207
-$69,804,103 QoQ
Shares Held
12,342,274
-10.3% QoQ
Ownership
0.500%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#30
of 3,778 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. MRK ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in MRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,585,982,207 | 12,342,274 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,655,786,310 | 13,764,954 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,408,914,884 | 13,385,093 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,276,926,709 | 15,214,187 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,308,725,123 | 16,532,657 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,173,855,772 | 13,077,716 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $948,609,437 | 9,535,680 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,824,782,339 | 16,068,883 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,603,062,544 | 12,948,809 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,671,313,914 | 12,666,267 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,349,496,969 | 12,378,435 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,497,790,710 | 14,548,720 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,476,910,867 | 12,799,297 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,324,258,125 | 12,447,205 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,165,815,771 | 10,507,578 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $950,971,825 | 11,042,404 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $694,746,204 | 7,620,338 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $691,371,504 | 8,426,222 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $393,820,839 | 5,138,581 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $667,123,859 | 8,881,958 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $784,977,930 | 10,093,583 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||